Concepedia

Publication | Open Access

Pertuzumab (P) + trastuzumab (H) + chemotherapy (CT) for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (mGC/GEJC): Final analysis of a Phase III study (JACOB)

DOIFull Paper Access

58

Citations

0

References

2017

Year

Josep Tabernero, Paulo M. Hoff, Lin Shen, Atsushi Ohtsu, Manish A. Shah, Kuo‐Sheng Cheng, Changhua Song, Haiyan Wu, Jennifer Eng‐Wong, Y-K. Kang
Annals of Oncology

No additional data available for this publication yet. Check back later!